Described herein are compositions and methods related to enhancing cardiomyocyte transplant engraftment and methods of administering a transplant composition.

Aspects of the present disclosure provide methods for treating a neurological disorder using a polyphosphate (polyP)-neutralizing molecule such as a phosphatase or a cationic polymer.